Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Working Capital Changes (2021 - 2025)

Historic Other Working Capital Changes for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $20569.0.

  • HeartSciences' Other Working Capital Changes rose 11244.1% to $20569.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$33871.0, marking a year-over-year increase of 8833.72%. This contributed to the annual value of -$357507.0 for FY2025, which is 5089.01% down from last year.
  • HeartSciences' Other Working Capital Changes amounted to $20569.0 in Q4 2025, which was up 11244.1% from $97746.0 recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Other Working Capital Changes ranged from a high of $97746.0 in Q3 2025 and a low of -$201244.0 during Q4 2023
  • For the 5-year period, HeartSciences' Other Working Capital Changes averaged around -$51912.3, with its median value being -$50247.0 (2022).
  • Data for HeartSciences' Other Working Capital Changes shows a peak YoY increase of 34443.22% (in 2025) and a maximum YoY decrease of 33260.89% (in 2025) over the last 5 years.
  • Over the past 5 years, HeartSciences' Other Working Capital Changes (Quarter) stood at $75520.0 in 2021, then plummeted by 273.43% to -$130976.0 in 2022, then plummeted by 53.65% to -$201244.0 in 2023, then rose by 17.85% to -$165332.0 in 2024, then surged by 112.44% to $20569.0 in 2025.
  • Its Other Working Capital Changes was $20569.0 in Q4 2025, compared to $97746.0 in Q3 2025 and -$117193.0 in Q2 2025.